Ten years in the making, and full implementation is finally coming. In about a year—beginning on November 27, 2023—prescription drug manufacturers and their supply chain partners will be required to fully trace and verify...more
As companies begin planning for the upcoming year, attorneys who sit on promotional review committees should consider the significant guidance published by the U.S. Food and Drug Administration (“FDA”) and update process aids...more
PART I-
On April 20, 2022, the Office of Inspector General (“OIG”) of the Department of Health and Human Services (“HHS”) issued Advisory Opinion, No. 22-07 (“Opinion 22-07”), an informative opinion regarding arrangements...more
8/30/2022
/ Anti-Kickback Statute ,
Beneficiaries ,
Business Ownership ,
Carve Out Provisions ,
Department of Health and Human Services (HHS) ,
Fraud Alerts ,
Irrevocable Trusts ,
Medical Devices ,
OIG ,
Ownership Interest ,
Physician Ownership